Examining AI’s Impact on the Future of Medtech

In a recent article published by Medical Device & Diagnostic Industry, thought leaders examine how artificial intelligence is shaping the medtech and healthcare landscape as organizations balance rapid innovation with regulatory, operational, and cybersecurity considerations.

Project Farma Founder & President of OneSource Life Sciences, Anshul Mangal, contributes commentary on how AI is influencing investment strategy across medtech, with a focus on targeted M&A and portfolio expansion. His perspective highlights the importance of alignment between technology, clinical impact, and reimbursement, as well as the growing role of AI in supporting predictable manufacturing, compliance automation, and scalable growth.

Click here to read, ‘Tracking How AI Will Impact the Medical Device Industry & Healthcare’.